Annovis Bio, Inc.
ANVS
Revenue
0.00
0.000.00%
12 Months ChangeAssets
5.05M
▼-2.77M▼-35.41%
3 Months ChangeLiabilities
6.80M
▼-4.37M▼-39.13%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001104659-24-108360
2024-09-30
Form 8-K
ID: 0001104659-24-104002
2024-08-15
Form 8-K
ID: 0001104659-24-089913
2024-08-14
Form 10-Q
ID: 0001558370-24-012227
2024-08-06
Form 8-K
ID: 0001104659-24-086114
2024-07-16
Form 8-K
ID: 0001104659-24-080039
2024-07-10
Form 8-K
ID: 0001104659-24-078937
2024-07-02
Form 8-K
ID: 0001104659-24-077093
2024-06-13
Form 8-K
ID: 0001104659-24-071011
2024-06-11
Form 8-K
ID: 0001104659-24-070450